Form 4: Voyager Therapeutics' Chief Legal Officer Sells Shares to Cover Tax Obligations

Jacquelyn Fahey Sandell, Chief Legal Officer of Voyager Therapeutics, sold shares of common stock to cover tax withholding obligations related to vesting restricted stock units.

Summary

• On February 11, 2025, Jacquelyn Fahey Sandell, the Chief Legal Officer of Voyager Therapeutics, sold 4,358 shares of common stock.
• The sale was executed to cover tax withholding obligations associated with the vesting of restricted stock units on February 9, 2025.
• The shares were sold at a weighted average price of $4.45, with individual transactions ranging from $4.13 to $5.00.
• Following the transaction, Sandell beneficially owns 81,643 shares of Voyager Therapeutics.
• The sale was conducted automatically under a pre-arranged sales instruction letter and does not represent a discretionary trade by Sandell.

Sentiment

Score: 5

Explanation: The document describes a routine transaction (sale of shares to cover tax obligations) and does not contain any information that would significantly impact investor sentiment positively or negatively.

Industry Context

Sales of shares by company insiders are a common occurrence, often related to compensation and tax obligations. These transactions are closely monitored by investors for insights into management's perspective on the company's value and prospects.

Key Dates

Keywords

Voyager Therapeutics, Jacquelyn Fahey Sandell, Form 4, SEC, Share Sale, Tax Obligations, Restricted Stock Units, VYGR, Chief Legal Officer